Investigational drugs to treat hemophilia-Reference-Cited by-同舟云学术

Investigational drugs to treat hemophilia

Published:2020-02-03 Issue:3 Volume:29 Page:295-301
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Franchini Massimo¹²,Marano Giuseppe¹,Pati Ilaria¹,Veropalumbo Eva¹,Vaglio Stefania¹,Pupella Simonetta¹^ORCID,Masiello Francesca¹,Cruciani Mario¹³,Mengoli Carlo¹,Liumbruno Giancarlo Maria¹

Affiliation:

1. Italian National Blood Centre, National Institute of Health, Rome, Italy

2. Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy

3. Infection Control Committee and Antibiotic Stewardship Programme, AULSS9 Scaligera, Verona, Italy

Funder

funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1722999

Reference54 articles.

1. The Hemophilias — From Royal Genes to Gene Therapy

2. Hemophilia A in the third millennium

3. Definitions in Hemophilia

4. Past, present and future of hemophilia: a narrative review

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitor eradication and treatment for acquired hemophilia A;Expert Review of Hematology;2024-05-09

2. Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B;Cochrane Database of Systematic Reviews;2024-02-27

3. Quantitative Systems Pharmacology for Rare Disease Drug Development;Journal of Pharmaceutical Sciences;2023-09

4. Hematological treatment and prophylaxis in patients with and without inhibitors;Blood Coagulation & Fibrinolysis;2023-06

5. From a bispecific monoclonal antibody to gene therapy: A new era in the treatment of hemophilia A;Biomedical Papers;2023-03-15